Global and China Preventable Vaccines Market Insights, Forecast to 2026

Publisher Name :
Date: 25-Sep-2020
No. of pages: 178
Inquire Before Buying

Preventable Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Preventable Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Preventable Vaccines market is segmented into

- Adult Preventable Vaccines

- Pediatric Preventable Vaccines

Segment by Application, the Preventable Vaccines market is segmented into

- Bacterial Diseases

- Virus Diseases

Regional and Country-level Analysis

The Preventable Vaccines market is analysed and market size information is provided by regions (countries).

The key regions covered in the Preventable Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Preventable Vaccines Market Share Analysis

Preventable Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventable Vaccines business, the date to enter into the Preventable Vaccines market, Preventable Vaccines product introduction, recent developments, etc.

The major vendors covered:

- GlaxoSmithKline

- Merck

- Novartis

- Pfizer

- Sanofi

- Takeda Pharmaceutical

- Abbott

- Roche

- AstraZeneca

- Mitsubishi Tanabe Pharma

- Lupin

- Serum Institute of India

- LG Life Sciences

- S K Chemicals

- Shenzhen Kangtai Biological Products

- Sinovac Biotech

- Janssen Pharmaceuticals

- Crucell

- Bavarian Nordic

- Baxter

- Bharat Biotech

- Dynavax

- Bausch Health

- Protein Sciences

- Panacea Biotec

Global and China Preventable Vaccines Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Preventable Vaccines Product Introduction
1.2 Market Segments
1.3 Key Preventable Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Preventable Vaccines Market Size Growth Rate by Type
1.4.2 Adult Preventable Vaccines
1.4.3 Pediatric Preventable Vaccines
1.5 Market by Application
1.5.1 Global Preventable Vaccines Market Size Growth Rate by Application
1.5.2 Bacterial Diseases
1.5.3 Virus Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Preventable Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Preventable Vaccines Revenue 2015-2026
2.1.2 Global Preventable Vaccines Sales 2015-2026
2.2 Global Preventable Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Preventable Vaccines Historical Market Size by Region (2015-2020)
2.3.1 Global Preventable Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Preventable Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Preventable Vaccines Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Preventable Vaccines Sales Forecast by Region (2021-2026)
2.4.2 Global Preventable Vaccines Revenue Forecast by Region (2021-2026)
3 Global Preventable Vaccines Competitor Landscape by Players
3.1 Global Top Preventable Vaccines Sales by Manufacturers
3.1.1 Global Preventable Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Global Preventable Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Global Preventable Vaccines Manufacturers by Revenue
3.2.1 Global Preventable Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Global Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Preventable Vaccines Revenue in 2019
3.2.5 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Preventable Vaccines Price by Manufacturers
3.4 Global Preventable Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Preventable Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventable Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Preventable Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Preventable Vaccines Market Size by Type (2015-2020)
4.1.1 Global Preventable Vaccines Sales by Type (2015-2020)
4.1.2 Global Preventable Vaccines Revenue by Type (2015-2020)
4.1.3 Preventable Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Preventable Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Preventable Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Preventable Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Preventable Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Preventable Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Preventable Vaccines Market Size by Application (2015-2020)
5.1.1 Global Preventable Vaccines Sales by Application (2015-2020)
5.1.2 Global Preventable Vaccines Revenue by Application (2015-2020)
5.1.3 Preventable Vaccines Price by Application (2015-2020)
5.2 Preventable Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Preventable Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Preventable Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventable Vaccines Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Preventable Vaccines Market Size YoY Growth 2015-2026
6.1.1 China Preventable Vaccines Sales YoY Growth 2015-2026
6.1.2 China Preventable Vaccines Revenue YoY Growth 2015-2026
6.1.3 China Preventable Vaccines Market Share in Global Market 2015-2026
6.2 China Preventable Vaccines Market Size by Players (International and Local Players)
6.2.1 China Top Preventable Vaccines Players by Sales (2015-2020)
6.2.2 China Top Preventable Vaccines Players by Revenue (2015-2020)
6.3 China Preventable Vaccines Historic Market Review by Type (2015-2020)
6.3.1 China Preventable Vaccines Sales Market Share by Type (2015-2020)
6.3.2 China Preventable Vaccines Revenue Market Share by Type (2015-2020)
6.3.3 China Preventable Vaccines Price by Type (2015-2020)
6.4 China Preventable Vaccines Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Preventable Vaccines Sales Forecast by Type (2021-2026)
6.4.2 China Preventable Vaccines Revenue Forecast by Type (2021-2026)
6.4.3 China Preventable Vaccines Price Forecast by Type (2021-2026)
6.5 China Preventable Vaccines Historic Market Review by Application (2015-2020)
6.5.1 China Preventable Vaccines Sales Market Share by Application (2015-2020)
6.5.2 China Preventable Vaccines Revenue Market Share by Application (2015-2020)
6.5.3 China Preventable Vaccines Price by Application (2015-2020)
6.6 China Preventable Vaccines Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Preventable Vaccines Sales Forecast by Application (2021-2026)
6.6.2 China Preventable Vaccines Revenue Forecast by Application (2021-2026)
6.6.3 China Preventable Vaccines Price Forecast by Application (2021-2026)
7 North America
7.1 North America Preventable Vaccines Market Size YoY Growth 2015-2026
7.2 North America Preventable Vaccines Market Facts & Figures by Country
7.2.1 North America Preventable Vaccines Sales by Country (2015-2020)
7.2.2 North America Preventable Vaccines Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Preventable Vaccines Market Size YoY Growth 2015-2026
8.2 Europe Preventable Vaccines Market Facts & Figures by Country
8.2.1 Europe Preventable Vaccines Sales by Country
8.2.2 Europe Preventable Vaccines Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Preventable Vaccines Market Size YoY Growth 2015-2026
9.2 Asia Pacific Preventable Vaccines Market Facts & Figures by Country
9.2.1 Asia Pacific Preventable Vaccines Sales by Region (2015-2020)
9.2.2 Asia Pacific Preventable Vaccines Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Preventable Vaccines Market Size YoY Growth 2015-2026
10.2 Latin America Preventable Vaccines Market Facts & Figures by Country
10.2.1 Latin America Preventable Vaccines Sales by Country
10.2.2 Latin America Preventable Vaccines Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Preventable Vaccines Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Preventable Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Preventable Vaccines Sales by Country
11.2.2 Middle East and Africa Preventable Vaccines Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Preventable Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Preventable Vaccines Products Offered
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Preventable Vaccines Products Offered
12.3.5 Novartis Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Description and Business Overview
12.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Preventable Vaccines Products Offered
12.4.5 Pfizer Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Preventable Vaccines Products Offered
12.5.5 Sanofi Recent Development
12.6 Takeda Pharmaceutical
12.6.1 Takeda Pharmaceutical Corporation Information
12.6.2 Takeda Pharmaceutical Description and Business Overview
12.6.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Takeda Pharmaceutical Preventable Vaccines Products Offered
12.6.5 Takeda Pharmaceutical Recent Development
12.7 Abbott
12.7.1 Abbott Corporation Information
12.7.2 Abbott Description and Business Overview
12.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Preventable Vaccines Products Offered
12.7.5 Abbott Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Roche Preventable Vaccines Products Offered
12.8.5 Roche Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Corporation Information
12.9.2 AstraZeneca Description and Business Overview
12.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.9.4 AstraZeneca Preventable Vaccines Products Offered
12.9.5 AstraZeneca Recent Development
12.10 Mitsubishi Tanabe Pharma
12.10.1 Mitsubishi Tanabe Pharma Corporation Information
12.10.2 Mitsubishi Tanabe Pharma Description and Business Overview
12.10.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Products Offered
12.10.5 Mitsubishi Tanabe Pharma Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Preventable Vaccines Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Serum Institute of India
12.12.1 Serum Institute of India Corporation Information
12.12.2 Serum Institute of India Description and Business Overview
12.12.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Serum Institute of India Products Offered
12.12.5 Serum Institute of India Recent Development
12.13 LG Life Sciences
12.13.1 LG Life Sciences Corporation Information
12.13.2 LG Life Sciences Description and Business Overview
12.13.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
12.13.4 LG Life Sciences Products Offered
12.13.5 LG Life Sciences Recent Development
12.14 S K Chemicals
12.14.1 S K Chemicals Corporation Information
12.14.2 S K Chemicals Description and Business Overview
12.14.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 S K Chemicals Products Offered
12.14.5 S K Chemicals Recent Development
12.15 Shenzhen Kangtai Biological Products
12.15.1 Shenzhen Kangtai Biological Products Corporation Information
12.15.2 Shenzhen Kangtai Biological Products Description and Business Overview
12.15.3 Shenzhen Kangtai Biological Products Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Shenzhen Kangtai Biological Products Products Offered
12.15.5 Shenzhen Kangtai Biological Products Recent Development
12.16 Sinovac Biotech
12.16.1 Sinovac Biotech Corporation Information
12.16.2 Sinovac Biotech Description and Business Overview
12.16.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Sinovac Biotech Products Offered
12.16.5 Sinovac Biotech Recent Development
12.17 Janssen Pharmaceuticals
12.17.1 Janssen Pharmaceuticals Corporation Information
12.17.2 Janssen Pharmaceuticals Description and Business Overview
12.17.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Janssen Pharmaceuticals Products Offered
12.17.5 Janssen Pharmaceuticals Recent Development
12.18 Crucell
12.18.1 Crucell Corporation Information
12.18.2 Crucell Description and Business Overview
12.18.3 Crucell Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Crucell Products Offered
12.18.5 Crucell Recent Development
12.19 Bavarian Nordic
12.19.1 Bavarian Nordic Corporation Information
12.19.2 Bavarian Nordic Description and Business Overview
12.19.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Bavarian Nordic Products Offered
12.19.5 Bavarian Nordic Recent Development
12.20 Baxter
12.20.1 Baxter Corporation Information
12.20.2 Baxter Description and Business Overview
12.20.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Baxter Products Offered
12.20.5 Baxter Recent Development
12.21 Bharat Biotech
12.21.1 Bharat Biotech Corporation Information
12.21.2 Bharat Biotech Description and Business Overview
12.21.3 Bharat Biotech Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Bharat Biotech Products Offered
12.21.5 Bharat Biotech Recent Development
12.22 Dynavax
12.22.1 Dynavax Corporation Information
12.22.2 Dynavax Description and Business Overview
12.22.3 Dynavax Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Dynavax Products Offered
12.22.5 Dynavax Recent Development
12.23 Bausch Health
12.23.1 Bausch Health Corporation Information
12.23.2 Bausch Health Description and Business Overview
12.23.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Bausch Health Products Offered
12.23.5 Bausch Health Recent Development
12.24 Protein Sciences
12.24.1 Protein Sciences Corporation Information
12.24.2 Protein Sciences Description and Business Overview
12.24.3 Protein Sciences Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Protein Sciences Products Offered
12.24.5 Protein Sciences Recent Development
12.25 Panacea Biotec
12.25.1 Panacea Biotec Corporation Information
12.25.2 Panacea Biotec Description and Business Overview
12.25.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
12.25.4 Panacea Biotec Products Offered
12.25.5 Panacea Biotec Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Preventable Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Preventable Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Preventable Vaccines Market Segments
Table 2. Ranking of Global Top Preventable Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Preventable Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Adult Preventable Vaccines
Table 5. Major Manufacturers of Pediatric Preventable Vaccines
Table 6. Global Preventable Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Preventable Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Preventable Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Preventable Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Preventable Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Preventable Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Preventable Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Preventable Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Preventable Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Preventable Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventable Vaccines as of 2019)
Table 16. Preventable Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Preventable Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Preventable Vaccines Price (2015-2020) (USD/Unit)
Table 19. Preventable Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Preventable Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Preventable Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Preventable Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global Preventable Vaccines Sales Share by Type (2015-2020)
Table 25. Global Preventable Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Preventable Vaccines Revenue Share by Type (2015-2020)
Table 27. Preventable Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Preventable Vaccines Sales Share by Type (2021-2026)
Table 29. Global Preventable Vaccines Sales by Application (2015-2020) (K Units)
Table 30. Global Preventable Vaccines Sales Share by Application (2015-2020)
Table 31. Global Preventable Vaccines Sales Share by Application (2021-2026)
Table 32. Global Preventable Vaccines Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Preventable Vaccines Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Preventable Vaccines Revenue Market Share Forecast by Application (2021-2026)
Table 35. China Preventable Vaccines Sales (K Units) of Key Companies (2015-2020)
Table 36. China Preventable Vaccines Sales Share by Company (2015-2020)
Table 37. China Preventable Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 38. China Preventable Vaccines Sales (K Units) by Type (2015-2020)
Table 39. China Preventable Vaccines Sales Share by Type (2015-2020)
Table 40. China Preventable Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. China Preventable Vaccines Price (K Units) by Type (2015-2020)
Table 42. China Preventable Vaccines Sales (K Units) by Type (2021-2026)
Table 43. China Preventable Vaccines Sales Share by Type (2021-2026)
Table 44. China Preventable Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. China Preventable Vaccines Revenue Share by Type (2021-2026)
Table 46. China Preventable Vaccines Price (K Units) by Type (2021-2026)
Table 47. China Preventable Vaccines Sales (K Units) by Application (2015-2020)
Table 48. China Preventable Vaccines Sales Share by Application (2015-2020)
Table 49. China Preventable Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. China Preventable Vaccines Sales (K Units) by Application (2021-2026)
Table 51. China Preventable Vaccines Sales Share by Application (2021-2026)
Table 52. China Preventable Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. China Preventable Vaccines Revenue Share by Application (2021-2026)
Table 54. North America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 55. North America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 56. North America Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Europe Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 59. Europe Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 60. Europe Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Preventable Vaccines Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Preventable Vaccines Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Preventable Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Preventable Vaccines Revenue Market Share by Region (2015-2020)
Table 66. Latin America Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 67. Latin America Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Preventable Vaccines Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Preventable Vaccines Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Preventable Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Preventable Vaccines Revenue Market Share by Country (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Business Overview
Table 76. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Preventable Vaccines Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Merck Corporation Information
Table 80. Merck Description and Business Overview
Table 81. Merck Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Merck Product
Table 83. Merck Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Business Overview
Table 86. Novartis Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Business Overview
Table 91. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Business Overview
Table 96. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. Takeda Pharmaceutical Corporation Information
Table 100. Takeda Pharmaceutical Description and Business Overview
Table 101. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Takeda Pharmaceutical Product
Table 103. Takeda Pharmaceutical Recent Development
Table 104. Abbott Corporation Information
Table 105. Abbott Description and Business Overview
Table 106. Abbott Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Abbott Product
Table 108. Abbott Recent Development
Table 109. Roche Corporation Information
Table 110. Roche Description and Business Overview
Table 111. Roche Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Roche Product
Table 113. Roche Recent Development
Table 114. AstraZeneca Corporation Information
Table 115. AstraZeneca Description and Business Overview
Table 116. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. AstraZeneca Product
Table 118. AstraZeneca Recent Development
Table 119. Mitsubishi Tanabe Pharma Corporation Information
Table 120. Mitsubishi Tanabe Pharma Description and Business Overview
Table 121. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Mitsubishi Tanabe Pharma Product
Table 123. Mitsubishi Tanabe Pharma Recent Development
Table 124. Lupin Corporation Information
Table 125. Lupin Description and Business Overview
Table 126. Lupin Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Lupin Product
Table 128. Lupin Recent Development
Table 129. Serum Institute of India Corporation Information
Table 130. Serum Institute of India Description and Business Overview
Table 131. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Serum Institute of India Product
Table 133. Serum Institute of India Recent Development
Table 134. LG Life Sciences Corporation Information
Table 135. LG Life Sciences Description and Business Overview
Table 136. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. LG Life Sciences Product
Table 138. LG Life Sciences Recent Development
Table 139. S K Chemicals Corporation Information
Table 140. S K Chemicals Description and Business Overview
Table 141. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. S K Chemicals Product
Table 143. S K Chemicals Recent Development
Table 144. Shenzhen Kangtai Biological Products Corporation Information
Table 145. Shenzhen Kangtai Biological Products Description and Business Overview
Table 146. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Shenzhen Kangtai Biological Products Product
Table 148. Shenzhen Kangtai Biological Products Recent Development
Table 149. Sinovac Biotech Corporation Information
Table 150. Sinovac Biotech Description and Business Overview
Table 151. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Sinovac Biotech Product
Table 153. Sinovac Biotech Recent Development
Table 154. Janssen Pharmaceuticals Corporation Information
Table 155. Janssen Pharmaceuticals Description and Business Overview
Table 156. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Janssen Pharmaceuticals Product
Table 158. Janssen Pharmaceuticals Recent Development
Table 159. Crucell Corporation Information
Table 160. Crucell Description and Business Overview
Table 161. Crucell Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Crucell Product
Table 163. Crucell Recent Development
Table 164. Bavarian Nordic Corporation Information
Table 165. Bavarian Nordic Description and Business Overview
Table 166. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Bavarian Nordic Product
Table 168. Bavarian Nordic Recent Development
Table 169. Baxter Corporation Information
Table 170. Baxter Description and Business Overview
Table 171. Baxter Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Baxter Product
Table 173. Baxter Recent Development
Table 174. Bharat Biotech Corporation Information
Table 175. Bharat Biotech Description and Business Overview
Table 176. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Bharat Biotech Product
Table 178. Bharat Biotech Recent Development
Table 179. Dynavax Corporation Information
Table 180. Dynavax Description and Business Overview
Table 181. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 182. Dynavax Product
Table 183. Dynavax Recent Development
Table 184. Bausch Health Corporation Information
Table 185. Bausch Health Description and Business Overview
Table 186. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 187. Bausch Health Product
Table 188. Bausch Health Recent Development
Table 189. Protein Sciences Corporation Information
Table 190. Protein Sciences Description and Business Overview
Table 191. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 192. Protein Sciences Product
Table 193. Protein Sciences Recent Development
Table 194. Panacea Biotec Corporation Information
Table 195. Panacea Biotec Description and Business Overview
Table 196. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 197. Panacea Biotec Product
Table 198. Panacea Biotec Recent Development
Table 199. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 200. Key Challenges
Table 201. Market Risks
Table 202. Main Points Interviewed from Key Preventable Vaccines Players
Table 203. Preventable Vaccines Customers List
Table 204. Preventable Vaccines Distributors List
Table 205. Research Programs/Design for This Report
Table 206. Key Data Information from Secondary Sources
Table 207. Key Data Information from Primary Sources
List of Figures
Figure 1. Preventable Vaccines Product Picture
Figure 2. Global Preventable Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Adult Preventable Vaccines Product Picture
Figure 4. Pediatric Preventable Vaccines Product Picture
Figure 5. Global Preventable Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Bacterial Diseases
Figure 7. Virus Diseases
Figure 8. Preventable Vaccines Report Years Considered
Figure 9. Global Preventable Vaccines Market Size 2015-2026 (US$ Million)
Figure 10. Global Preventable Vaccines Sales 2015-2026 (K Units)
Figure 11. Global Preventable Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Preventable Vaccines Sales Market Share by Region (2015-2020)
Figure 13. Global Preventable Vaccines Sales Market Share by Region in 2019
Figure 14. Global Preventable Vaccines Revenue Market Share by Region (2015-2020)
Figure 15. Global Preventable Vaccines Revenue Market Share by Region in 2019
Figure 16. Global Preventable Vaccines Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Preventable Vaccines Revenue in 2019
Figure 18. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Preventable Vaccines Sales Market Share by Type (2015-2020)
Figure 20. Global Preventable Vaccines Sales Market Share by Type in 2019
Figure 21. Global Preventable Vaccines Revenue Market Share by Type (2015-2020)
Figure 22. Global Preventable Vaccines Revenue Market Share by Type in 2019
Figure 23. Global Preventable Vaccines Market Share by Price Range (2015-2020)
Figure 24. Global Preventable Vaccines Sales Market Share by Application (2015-2020)
Figure 25. Global Preventable Vaccines Sales Market Share by Application in 2019
Figure 26. Global Preventable Vaccines Revenue Market Share by Application (2015-2020)
Figure 27. Global Preventable Vaccines Reve
  • Global and Japan POC Infectious Diseases Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 95
    Global POC Infectious Diseases Scope and Market Size POC Infectious Diseases market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global POC Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product c......
  • Global and China Photomedicine Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 131
    Global Photomedicine Scope and Market Size Photomedicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Photomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Skin......
  • Global and Japan Pediatric Medicines Market Insights, Forecast to 2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 140
    Pediatric Medicines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Pediatric Medicines market is seg......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 146
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 142
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Moxifloxacin HCl Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 26-Oct-2020        Price: US 3160 Onwards        Pages: 126
    Summary At the time of this report, the official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial ch......
  • (Post-pandemic Era) - Global Protein Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 26-Oct-2020        Price: US 4860 Onwards        Pages: 103
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Protein Drugs growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related reg......
  • (Post-pandemic Era) - Global Protein Drugs Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 26-Oct-2020        Price: US 3650 Onwards        Pages: 134
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • (Post-pandemic Era) - Global Protein Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 26-Oct-2020        Price: US 3620 Onwards        Pages: 138
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs